Quantcast

Latest Aura Stories

2009-03-13 22:29:14

More women than men die from stroke each year but many women think stroke is a man's disease, a U.S. researcher says. Jan Flewelling of the Methodist Neurological Institute in Houston says stroke kills twice as many women as breast cancer does, but many women still think stroke is a man's disease and women are less likely to report classic stroke symptoms than men. While women need to be aware of the common risk factors for stroke -- high blood pressure, diabetes and high cholesterol -- some...

79886deb7dd7dc528937d9bbe33be0441
2009-03-11 10:05:20

A U.S. study proposes that migraines can increase the risk of a stroke during pregnancy, BBC news reports.  Yet, a study conducted by the British Medical Journal emphasizes the overall danger is low.  The study also linked raised risk of heart disease, blood clots and high blood pressure to the headaches.  The migraine puts added tension on the body when it is already fighting with higher blood volume and increased heart rate, researchers infer.  It may be likely,...

2009-02-17 10:28:15

New research looks at whether a gene variant may affect the link between migraine and stroke or heart attacks. The study is published in the February 17, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.The study involved 25,000 women who answered a questionnaire about their history of migraines and migraines with aura. Aura is usually described as visual disturbances, such as flashing lights or geometric patterns. The women were...

2c744ff7f10002a0a87e4c7038d926cc1
2008-12-16 16:50:00

Chinese government regulators had clearer skies and easier breathing in mind in the summer of 2008 when they temporarily shuttered some factories and banished many cars in a pre-Olympic sprint to clean up Beijing's air. And that's what they got. They were not necessarily planning for something else: an unprecedented experiment using satellites to measure the impact of air pollution controls. Taking advantage of the opportunity, NASA researchers have since analyzed data from NASA's Aura and...

2008-10-27 12:00:30

Minster Pharmaceuticals, a drug development company, has announced positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. According to the company, the median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary endpoint of the study is both clinically and statistically highly significant. A further primary endpoint showed a reduction in the number of...

2008-09-08 12:00:41

NeurAxon, a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase, has announced encouraging data from its Phase II clinical trial of NXN-188 in patients with migraine. In the study, patients experiencing migraine with aura achieved sustained relief from their headaches, representing a potentially differentiated treatment profile from current migraine therapies. Data from the Phase II trial showed that patients receiving NXN-188 experienced a 15% greater...

2008-09-05 09:00:38

NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced data from its Phase 2 clinical trial of NXN-188 in patients with migraine. In the study, patients experiencing migraine with aura, which represents over 7 million patients in the US, achieved sustained relief from their headaches, representing a potentially differentiated treatment profile from current migraine therapies. These data were presented in a session at...

2008-07-03 12:00:13

U.S. medical scientists say they may have found clues to the biological basis of migraine headaches suffered by 15 percent to 20 percent of people worldwide. By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center led by Dr. Alfred George Jr. determined genetic mutations linked to the rare form of familial migraine alter the function of sodium channels -- protein tunnels through brain cell membranes involved in the electrical conduction of nerve...

e11e4409afee073fcc6017ca61d0e9751
2008-06-26 09:00:00

Neuralieve, a medical technology company pioneering a new approach to treat migraine headache, today reported completion of its clinical trial. The results will be presented June 27 during the annual American Headache Society (AHS) scientific meeting in Boston by Dr. Richard B. Lipton, Professor and Vice Chair of Neurology and Professor of Epidemiology and Population Health at the Albert Einstein College of Medicine in New York. The randomized, double-blind, parallel-group, sham-controlled...

2008-06-17 09:00:00

By Jeremy Laurance It's notoriously hard to treat, but doctors are closer than ever to finding effective relief for this condition that affects millions. Jeremy Laurance offers a sufferers' guide WHO GETS IT? An estimated six million adults in Britain, or 15 per cent of the population, are migraine sufferers. The condition affects one in four women and one in 12 men and is the commonest reason for consulting a neurologist. Up to a third of patients in some neurology clinics are seeking...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related